Santen Pharmaceutical Co., Ltd.
4536
Classement en actions
#4331
Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research,... Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available for sale in Japan; DE-126, progressing through Phase IIb trials; DE-128, which is on the market in Europe and undergoing Phase II/III trials in the United States; and DE-130A, also in Phase III development. Beyond glaucoma, Santen's offerings extend to other ocular ailments. It provides DE-114A for allergic conjunctivitis and DE-076C for vernal keratoconjunctivitis. Furthermore, DE-109 is in Phase III clinical trials for the treatment of uveitis. The company is also active in addressing myopia with DE-127, currently in Phase II/III trials in Japan and Phase III in other Asian markets, alongside STN1013400, which is in Phase I trials. For dry eye, Santen offers DE-089C, which has successfully concluded its Phase III clinical trials. In addition to its prescription portfolio, the company produces and sells various over-the-counter (OTC) pharmaceutical products. Founded in 1890 under the name Santendo Pharmaceutical Co., Ltd., the company rebranded to its current name, Santen Pharmaceutical Co., Ltd., in 1958. It is headquartered in Osaka, Japan.
Prix de l'action
$11.35
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$3.65B
Changement (1 jour)
1.55%
Changement (1 an)
-0.91%
Pays
JP
Échange Santen Pharmaceutical Co., Ltd. (4536)
Catégorie
Healthcare
Capitalisation boursière de Santen Pharmaceutical Co., Ltd.(4536)
Capitalisation boursière: $3.65B
En October 2026, Santen Pharmaceutical Co., Ltd. a une capitalisation boursière de $3.65B. Cela fait de Santen Pharmaceutical Co., Ltd. la 4331st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Santen Pharmaceutical Co., Ltd. du 2010 au 2026
4536 par rapport au top 5 des plus populaires stocks
